Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Artivion, Inc.AORT-1,538.053.404.3022.20-0.30%0.39%41.65$30.56-$4.8814,372$31.28

Detail of Artivion, Inc.

 
CEO
Mr. James Patrick Mackin
Employees
1300
Industry
Medical Devices
Sector
Healthcare
Market cap
$1B

Company details

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$384.90M
Cost of goods (CoG)
-$136.52M
Gross profit (GP)
$248.37M
Operating expense (OE)
-$209.00M
Research and development (R&D)
-$28.69M
General and administrative (G&A)
-$180.30M
Operating income (OI)
$39.38M
Other income expense (OIE)
-$1.59M
Pretax income (PI)
$8.50M
Tax (TAX)
-$9.35M
Net income (NI)
-$851,000.00
Artivion, Inc.
AORT • XNYS • US
$31.28
+14.57 (87.25%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.12
Payout ratio
0.00%
EPS
-$0.02
Margin profit
-0.22%
52 week low
$17.030001
52 week high
$32.179001
50-day simple moving average
$31.06
200-day simple moving average
$30.56
Percent held by insiders
5.48%
Percent held by institutions
87.62%
Dividend yield
0.39%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
AORT +84.05%
eps change
AORT 0.00%